American International Group, Inc. Rubius Therapeutics, Inc. Transaction History

American International Group, Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.79 - $5.98 $18,013 - $136,355	-22,802 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$4.25 - $10.4 $6,825 - $16,702	-1,606 Reduced 6.58%	22,802 $126,000
Q4 2021 Feb 11, 2022	SELL	$9.68 - $17.74 $7,066 - $12,950	-730 Reduced 2.9%	24,408 $236,000
Q3 2021 Nov 12, 2021	SELL	$17.6 - $25.91 $2,200 - $3,238	-125 Reduced 0.49%	25,138 $449,000
Q2 2021 Aug 13, 2021	BUY	$22.26 - $28.43 $97,365 - $124,352	4,374 Added 20.94%	25,263 $617,000
Q1 2021 May 07, 2021	BUY	$8.02 - $32.01 $441 - $1,760	55 Added 0.26%	20,889 $554,000
Q4 2020 Feb 12, 2021	SELL	$4.23 - $8.73 $2,533 - $5,229	-599 Reduced 2.79%	20,834 $158,000
Q3 2020 Nov 04, 2020	SELL	$4.65 - $6.25 $2,259 - $3,037	-486 Reduced 2.22%	21,433 $107,000
Q2 2020 Aug 12, 2020	BUY	$4.01 - $6.88 $4,952 - $8,496	1,235 Added 5.97%	21,919 $131,000
Q1 2020 May 04, 2020	SELL	$3.74 - $9.84 $4,473 - $11,768	-1,196 Reduced 5.47%	20,684 $92,000
Q4 2019 Feb 05, 2020	SELL	$7.23 - $14.12 $1,337 - $2,612	-185 Reduced 0.84%	21,880 $208,000
Q3 2019 Nov 08, 2019	SELL	$7.85 - $15.75 $1,201 - $2,409	-153 Reduced 0.69%	22,065 $173,000
Q2 2019 Aug 13, 2019	BUY	$13.5 - $19.94 $6,507 - $9,611	482 Added 2.22%	22,218 $349,000
Q1 2019 May 06, 2019	BUY	$13.27 - $18.51 $182,130 - $254,049	13,725 Added 171.33%	21,736 $393,000
Q4 2018 Feb 13, 2019	SELL	$13.83 - $22.97 $843 - $1,401	-61 Reduced 0.76%	8,011 $129,000
Q3 2018 Nov 09, 2018	BUY	$20.06 - $26.94 $161,924 - $217,459	8,072 New	8,072 $194,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.